Description: Eastgate Biotech Corp. is a pharmaceutical company. The Company is primarily engaged in the development of formulations of natural compounds and pharmaceutical products. The Company produces and distributes healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. The Company offers EGP-1214, a compressed tablet containing human recombinant insulin that is designed for sublingual administration. It offers a range of products, such as E-Drops, which is used to combat urinary and vaginal tract infections; Essential D, which is an enhanced Vitamin D3, working to improve the body's digestive, cardiovascular, and immune systems; Puralen, is an all-natural herbal cleanse of colon and the urinary tract; GluCora, which prevents fat deposition; VCleanzz, which is an antibacterial wash for fruits and vegetables; Cleanezze, which is a natural hand sanitizer, and Warts X, which is a natural herbal product that treats warts.
Home Page: www.EastGateBiotech.com
65 Harbour Square
Toronto,
ON
M5J 2L4
Canada
Phone:
647-692-0652
Officers
| Name | Title |
|---|---|
| Ms. Rosella C. Perri | CEO, Sec., Treasurer & Director |
| Dr. Mirjana Hasanagic | VP of Natural Products |
| Mr. William D. Abajian | Vice Chairman, Pres & COO |
| Dr. Joseph Schwarz Ph.D. | Chief Scientific Officer |
| Dr. Michael Weisspapir | Chief Medical Officer |
Exchange: OTCCE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 31.2365 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |